References
- Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27.
- Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
- Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193.
- Audet-Walsh É, Giguére V. The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases. Acta Pharmacol Sin. 2015;36(1):51–61.
- Fujisawa H. Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J Neurobiol. 2004;59(1):24–33.
- Yasuoka H, Kodama R, Tsujimoto M, et al. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer. 2009;9(1):220.
- Tu DG, Chang WW, Jan MS, et al. Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction. Oncol Lett. 2016;12(5):4224–4230.
- Zhang B, Gao Z, Sun M, et al. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis. J Surg Oncol. 2015;111(4):382–388.
- Nie N, Wu XL, Yu HH, et al. Expressions and clinical significance of Neuropilin-1 and Neuropilin-2 in human gastric cancer. Chin J Gastroenterol Hepatol. 2017;26(12):1340–1344. Articlein Chinese. https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2018&filename=WCBX201712006&uniplatform=NZKPT&v=Yd7E9B7EzfbTNVYIC9tujWzrsmEjvucUEFVdAuk-qZ0LhfTTs-cEb5nNR0DBnzdg
- Xu WG, Yang XQ, He SZ, et al. The expression of neuropilin-1 and its correlation with angiogenesis in colorectal cancer. Chin Clin Oncol. 2009;14(1):29–33. [Articlein Chinese]. https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2009&filename=LCZL200901008&uniplatform=NZKPT&v=iSYu6zbM4u2TLyhnua45BJcH_UHPU1AiVaHItzmXibVivnyvI3uknv71luyBtvb3
- Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691.
- Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–458.
- West DC, Rees CG, Duchesne L, et al. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem. 2005;280(14):13457–13464.
- Yasuoka H, Kodama R, Hirokawa M, et al. Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype. J Clin Endocrinol Metab. 2011;96(11):E1857–E1861.
- Rushing EC, Stine MJ, Hahn SJ, et al. Neuropilin-2: a novel biomarker for malignant melanoma? Hum Pathol. 2012;43(3):381–389.